DK1041966T3 - Farmaceutiske præparater omfattende zafirlukast - Google Patents

Farmaceutiske præparater omfattende zafirlukast

Info

Publication number
DK1041966T3
DK1041966T3 DK98960024T DK98960024T DK1041966T3 DK 1041966 T3 DK1041966 T3 DK 1041966T3 DK 98960024 T DK98960024 T DK 98960024T DK 98960024 T DK98960024 T DK 98960024T DK 1041966 T3 DK1041966 T3 DK 1041966T3
Authority
DK
Denmark
Prior art keywords
zafirlukast
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
DK98960024T
Other languages
Danish (da)
English (en)
Inventor
Susan Jane Corvari
Joseph Richard Creekmore
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Application granted granted Critical
Publication of DK1041966T3 publication Critical patent/DK1041966T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98960024T 1997-12-18 1998-12-15 Farmaceutiske præparater omfattende zafirlukast DK1041966T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726735.5A GB9726735D0 (en) 1997-12-18 1997-12-18 Pharmaceutical compositions
PCT/GB1998/003765 WO1999032082A2 (en) 1997-12-18 1998-12-15 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK1041966T3 true DK1041966T3 (da) 2003-10-06

Family

ID=10823809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98960024T DK1041966T3 (da) 1997-12-18 1998-12-15 Farmaceutiske præparater omfattende zafirlukast

Country Status (30)

Country Link
US (1) US6399104B1 (tr)
EP (1) EP1041966B1 (tr)
JP (1) JP2001526206A (tr)
KR (1) KR20010033206A (tr)
CN (1) CN1282244A (tr)
AR (1) AR017884A1 (tr)
AT (1) ATE243999T1 (tr)
AU (1) AU744326C (tr)
BR (1) BR9813666A (tr)
CA (1) CA2313163A1 (tr)
DE (1) DE69816124T2 (tr)
DK (1) DK1041966T3 (tr)
EE (1) EE04260B1 (tr)
ES (1) ES2202915T3 (tr)
GB (1) GB9726735D0 (tr)
HU (1) HUP0004669A3 (tr)
ID (1) ID25857A (tr)
IL (1) IL136501A0 (tr)
IN (1) IN191311B (tr)
MY (1) MY133096A (tr)
NO (1) NO20003141L (tr)
NZ (1) NZ504566A (tr)
PL (1) PL341736A1 (tr)
PT (1) PT1041966E (tr)
RU (1) RU2205006C2 (tr)
SK (1) SK9402000A3 (tr)
TR (1) TR200001713T2 (tr)
UA (1) UA62991C2 (tr)
WO (1) WO1999032082A2 (tr)
ZA (1) ZA9811532B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
BRPI0714963A2 (pt) * 2006-08-16 2013-07-30 Novartis Ag processo de fabricaÇço de dispersÕes sàlidas de compostos terapÊuticos altamente cristalinos
CN101677958A (zh) * 2007-03-26 2010-03-24 帝国制药株式会社 用于结肠-特异性递送的口服药物制剂
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
CA3052071A1 (en) 2017-01-30 2018-08-02 Western New England University Thiol isomerases inhibitors and use thereof
CN107714694A (zh) * 2017-11-01 2018-02-23 天津国际生物医药联合研究院 扎鲁司特在抗结核分枝杆菌感染中的应用
US20220370401A1 (en) 2021-05-19 2022-11-24 Quercis Pharma AG Method for treating amyotrophic lateral sclerosis using quercetin-containing compositions
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
IN191311B (tr) 2003-11-22
AR017884A1 (es) 2001-10-24
MY133096A (en) 2007-10-31
WO1999032082A3 (en) 1999-09-16
EE200000330A (et) 2001-08-15
PL341736A1 (en) 2001-05-07
IL136501A0 (en) 2001-06-14
NO20003141D0 (no) 2000-06-16
DE69816124D1 (de) 2003-08-07
HUP0004669A3 (en) 2005-03-29
EP1041966A2 (en) 2000-10-11
RU2205006C2 (ru) 2003-05-27
ZA9811532B (en) 1999-06-18
TR200001713T2 (tr) 2000-10-23
ES2202915T3 (es) 2004-04-01
HUP0004669A1 (hu) 2001-08-28
ID25857A (id) 2000-11-09
NO20003141L (no) 2000-06-16
EE04260B1 (et) 2004-04-15
PT1041966E (pt) 2003-11-28
NZ504566A (en) 2002-10-25
ATE243999T1 (de) 2003-07-15
AU744326B2 (en) 2002-02-21
SK9402000A3 (en) 2001-01-18
JP2001526206A (ja) 2001-12-18
EP1041966B1 (en) 2003-07-02
BR9813666A (pt) 2000-10-10
CN1282244A (zh) 2001-01-31
UA62991C2 (en) 2004-01-15
KR20010033206A (ko) 2001-04-25
AU1571199A (en) 1999-07-12
GB9726735D0 (en) 1998-02-18
CA2313163A1 (en) 1999-07-01
DE69816124T2 (de) 2004-05-06
AU744326C (en) 2002-11-07
US6399104B1 (en) 2002-06-04
WO1999032082A2 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
ID23874A (id) Obat
DE69828330D1 (de) Aktiviertes Protein C Formulierungen
ID24654A (id) Formulasi farmasi omeprazola
FI973244A (fi) Farmaseuttisia valmisteita nenänsisäiseen käyttöön
NO995712D0 (no) Oftalmiske preparater
NO980546D0 (no) Farmasöytiske midler
ATE266383T1 (de) Dermatologische zubereitungen
DK1017392T3 (da) Lægemiddel
ID16781A (id) Formulasi-formulasi farmasi
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
NO994619L (no) Farmasöytiske blandinger
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
DE69926012D1 (de) Arzneizubereitungen
MA26531A1 (fr) Composition pharmaceutique
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
DE69906934D1 (de) Arzneizubereitungen
ID23531A (id) Komposisi farmasi
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
UA25523A (uk) Лікувальhий препарат гірчичhик
ID21180A (id) Senyawa-senyawa farmasi